Deaths From Drug-Resistant Infections Set To Skyrocket

January 8th, 2015
in News, econ_news, syndication

from Felix Richter,
by Niall McCarthy

According to a recent report, drug-resistant infections are set to skyrocket and they could cost the global economy as much as $100 trillion by 2050.

Follow up:

Many diseases are growing increasingly resistant to the drugs used to treat them and the report notes that a new strain of E. coli has emerged that is immune to the previous class of antibiotics used to treat it successfully. Worse still, drug-resistant infections will kill more people than cancer in just over three decades. By 2050, ten million people are set to lose their lives every year unnecessarily unless drastic action is taken to tackle the problem.

This chart shows deaths from antimicrobial resistant infections and other causes in 2050.

Infographic: Deaths From Drug-Resistant Infections Set To Skyrocket | Statista
You will find more statistics at Statista


Make a Comment

Econintersect wants your comments, data and opinion on the articles posted.  As the internet is a "war zone" of trolls, hackers and spammers - Econintersect must balance its defences against ease of commenting.  We have joined with Livefyre to manage our comment streams.

To comment, just click the "Sign In" button at the top-left corner of the comment box below. You can create a commenting account using your favorite social network such as Twitter, Facebook, Google+, LinkedIn or Open ID - or open a Livefyre account using your email address.



Analysis Blog
News Blog
Investing Blog
Opinion Blog
Precious Metals Blog
Markets Blog
Video of the Day


Asia / Pacific
Middle East / Africa
USA Government

RSS Feeds / Social Media

Combined Econintersect Feed

Free Newsletter

Marketplace - Books & More

Economic Forecast

Content Contribution



  Top Economics Site Contributor TalkMarkets Contributor Finance Blogs Free PageRank Checker Active Search Results Google+

This Web Page by Steven Hansen ---- Copyright 2010 - 2016 Econintersect LLC - all rights reserved